Covered recipient · General Payments record
MARY EASTHAM
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2022–2023
$931.18
- Reported across 38 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $792.33 | 31 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $384.95 | 15 |
| ITI, Inc. | $125.99 | 1 |
| Amgen Inc. | $73.18 | 3 |
| Lilly USA, LLC | $41.70 | 2 |
| Edwards Lifesciences Corporation | $34.18 | 2 |
| IMPEL PHARMACEUTICALS INC. | $29.51 | 2 |
| Acerta Pharma LLC | $28.73 | 2 |
| GlaxoSmithKline, LLC. | $22.45 | 1 |
| Novo Nordisk AS | $22.37 | 1 |
| SHIELD THERAPEUTICS INC | $14.87 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $14.40 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (31)
Sorted by paying entity, then date · as published by CMS
Program year 2023 2022
Record-level detail is published for PY2023; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $18.43 | 02/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863347 | CMS |
| ABBVIE INC. | $23.13 | 03/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863355 | CMS |
| ABBVIE INC. | $30.32 | 03/08/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863365 | CMS |
| ABBVIE INC. | $3.32 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863373 | CMS |
| ABBVIE INC. | $5.87 | 03/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863379 | CMS |
| ABBVIE INC. | $21.47 | 03/29/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863387 | CMS |
| ABBVIE INC. | $124.99 | 04/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863395 | CMS |
| ABBVIE INC. | $28.11 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863403 | CMS |
| ABBVIE INC. | $28.05 | 05/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863411 | CMS |
| ABBVIE INC. | $7.46 | 05/31/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863419 | CMS |
| ABBVIE INC. | $9.57 | 06/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863427 | CMS |
| ABBVIE INC. | $12.68 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863435 | CMS |
| ABBVIE INC. | $31.80 | 06/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863443 | CMS |
| ABBVIE INC. | $25.22 | 06/21/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863451 | CMS |
| ABBVIE INC. | $14.53 | 06/28/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003863459 | CMS |
| Amgen Inc. | $29.25 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020434119 | CMS |
| Amgen Inc. | $29.25 | 03/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020434121 | CMS |
| Amgen Inc. | $14.68 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1020778723 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.60 | 01/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016138129 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.13 | 04/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1014494603 | CMS |
| Edwards Lifesciences Corporation | $18.01 | 05/17/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023200205 | CMS |
| Edwards Lifesciences Corporation | $16.17 | 08/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023200239 | CMS |
| GlaxoSmithKline, LLC. | $22.45 | 05/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1003949753 | CMS |
| IMPEL PHARMACEUTICALS INC. | $14.20 | 01/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989456037 | CMS |
| IMPEL PHARMACEUTICALS INC. | $15.31 | 04/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 989456045 | CMS |
| ITI, Inc. | $125.99 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1040878339 | CMS |
| Lilly USA, LLC | $19.86 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033376859 | CMS |
| Lilly USA, LLC | $21.84 | 05/10/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1033376871 | CMS |
| Novartis Pharmaceuticals Corporation | $14.40 | 01/25/2023 | Food and Beverage | Undisputed | 01/23/2026 | 991654471 | CMS |
| Novo Nordisk Inc | $22.37 | 02/16/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1002637303 | CMS |
| Shield Therapeutics Inc | $14.87 | 03/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1045737655 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023
- Source files
- Dataset page · Bulk file · PY2022 , PY2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.